Immediately preceding the Targeted Cancer Therapies Conference

Overview

The progress in developing cancer vaccine therapies is picking up speed. Several hundred clinical trials exist and many of them are in Phase III. While the common goal for cancer immunotherapeutics is to boost the immune system and thereby fight cancer in various stages, the approaches to reach this goal vary widely and many obstacles and challenges still need to be overcome. Many questions need to be answered and discussed. What are the advantages of a whole cell vaccine? How can efficiency be increased while side effects are being reduced? Will new technologies in proteomics, comparative genomics or molecular immunology accelerate the development of effective therapeutic vaccines? Molecular markers – do they predict efficiency? In its second year, this conference brings together the scientific experts to “brainstorm” in panels, sessions and roundtable discussions case studies and new discoveries in Cancer Immunotherapies.

Don't Miss these Back to Back Events offering....

	Sessions on….  Immunogenicity/ Immunomodulation, All about...Kines, Dendritic Cells, Radiopharmaceuticals, Antibodies, Using Phage Display, Technological Progress, Anti – Angiogenesis, HDAC, Signal Transduction, Personalized Immunotherapy and Small Molecule Therapeutics
	Two Networking Luncheons....  Sponsored by CHI
	See the Latest Products and Services in the Exhibit Hall
	Present a Scientific Poster..... & Save $50
	Poster Snapshots.... Several Posters Presenters will be selected to present a brief oral presentation of their work
	Kick-Off Keynote.... The Use of Cancer Vaccines in Combinatorial Therapies Dr. Jeffrey Schlom, Chief, Laboratory of Tumor Immunology and Biology,  National Cancer Institute, NIH
	Keynote Presentation Immune Monitoring Dr. Rafick-Pierre Sékaly, Professor, Laboratory of Immunology, Unversity de Montreal; Scientific Director, CANVAC
	Featured Presentation.... Funding Opportunities for Preclinical Research at the National Cancer Institute Dr. Min Song, Program Director, Division of Cancer Treatment and Diagnosis,  National Cancer Institute, NIH
	Panel Discussion..... Current Bottlenecks in Targeted Cancer Therapeutics

For sponsorship/exhibit information, please contact:
Suzanne Carroll, Manager, Business Development
Phone: 781-972-5452 • E-mail: scarroll@healthtech.com